Indian pharma threatened by COVID-19 shutdowns in China

Lancet. 2020 Feb 29;395(10225):675. doi: 10.1016/S0140-6736(20)30459-1.
No abstract available

MeSH terms

  • COVID-19
  • Chemistry, Pharmaceutical
  • China
  • Coronavirus Infections*
  • Drug Industry*
  • Humans
  • India
  • Pharmaceutical Preparations / supply & distribution
  • Pneumonia, Viral*

Substances

  • Pharmaceutical Preparations